Fibroblast Growth Factor Receptor Stocks List
Symbol | Grade | Name | % Change |
---|---|---|---|
BPMC | D | Blueprint Medicines Corporation | -5.84 |
NGM | C | NGM Biopharmaceuticals, Inc. | 4.04 |
BBIO | C | BridgeBio Pharma, Inc. | -3.43 |
FUSN | F | Fusion Pharmaceuticals Inc. | -0.51 |
RLAY | F | Relay Therapeutics, Inc. | -2.72 |
KNTE | F | Kinnate Biopharma Inc. | 3.35 |
Related Industries:
Biotechnology
Related Stock Lists:
Fibroblast Growth Factor
Tyrosine Kinase Receptors
Solid Tumors
Tyrosine Kinase
Biopharmaceutical
Cancer
Cell Biology
Clinical Development
Insulin
Precision Medicine
Protein Kinase Inhibitor
Achondroplasia
Advanced Solid Tumors
Age Related Macular Degeneration
Alcohol
Amyloid
Amyloidosis
Anatomy
Antibodies
Biopharmaceuticals
Related ETFs - A few ETFs which own one or more of the above listed Fibroblast Growth Factor Receptor stocks.
Symbol | Grade | Name | Weight |
---|---|---|---|
LRNZ | D | TrueMark Technology, AI & Deep Learning ETF | 3.85 |
IDNA | D | iShares Genomics Immunology and Healthcare ETF | 3.64 |
IBBJ | F | Defiance Nasdaq Junior Biotechnology ETF | 3.52 |
GNOM | D | Global X Genomics & Biotechnology ETF | 2.94 |
SBIO | D | ALPS Medical Breakthroughs ETF | 2.93 |
View all Fibroblast Growth Factor Receptor related ETFs...
Compare ETFs
Date | Stock | Signal | Type |
---|---|---|---|
2021-03-03 | BBIO | 20 DMA Resistance | Bearish |
2021-03-03 | BBIO | MACD Bearish Signal Line Cross | Bearish |
2021-03-03 | BBIO | 50 DMA Resistance | Bearish |
2021-03-03 | BPMC | 20 DMA Resistance | Bearish |
2021-03-03 | FUSN | 20 DMA Resistance | Bearish |
2021-03-03 | FUSN | 50 DMA Resistance | Bearish |
2021-03-03 | FUSN | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup |
2021-03-03 | KNTE | 20 DMA Resistance | Bearish |
2021-03-03 | NGM | MACD Bullish Centerline Cross | Bullish |
2021-03-03 | NGM | Crossed Above 50 DMA | Bullish |
2021-03-03 | NGM | Crossed Above 20 DMA | Bullish |
Related Industries:
Biotechnology
Related Stock Lists:
Fibroblast Growth Factor
Tyrosine Kinase Receptors
Solid Tumors
Tyrosine Kinase
Biopharmaceutical
Cancer
Cell Biology
Clinical Development
Insulin
Precision Medicine
Protein Kinase Inhibitor
Achondroplasia
Advanced Solid Tumors
Age Related Macular Degeneration
Alcohol
Amyloid
Amyloidosis
Anatomy
Antibodies
Biopharmaceuticals
Mike's Notes
- CGNT: Not a chart ...
- TDOC: One of sever...
- NFLX: I love these...
- CGEM: The Hot IPO ...
- X: A 17% breako...
From the Blog
Popular Now
Featured Articles
- Tech Stock Indices: Do Bulls Have A Problem?
- Robinhood Proxies – The Private and Public Markets Can Be Very Connected
- The Rise of Cult Stocks
- If you don’t know why you’re getting in, it will be even harder to get out
- Three Ways To Make Better Decisions in Markets
- Semi-automating Your Trading
- Recommended Stock Trading Books